Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT02021032 · UNKNOWN

Trial details

NCT number: NCT02021032
Sponsor: Medifocus, Inc.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Benign Prostate Hyperplasia

Start date: 2006-02-01
Primary completion: 2018-02-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.